NAD+ Peptide: Anti-Aging and Cellular Energy Research Guide

——-|——–|———–|———-|

Standard anti-aging 250-500 mg 1-2x weekly 4-8 weeks Higher dose studies 500-1000 mg 1x weekly 4-6 weeks Loading phase 500 mg 2x weekly 2 weeks Maintenance 250 mg Every 2-4 weeks Ongoing Neurological research 500-750 mg 1-2x weekly 8-12 weeks

Subcutaneous/Intramuscular Research Dosage

Protocol Dosage Frequency Notes Standard research 100-250 mg 2-3x weekly Slower absorption than IV Maintenance 100 mg 1-2x weekly For ongoing studies Combination with peptides 100-200 mg 2x weekly With CJC-1295, Ipamorelin, etc.

Oral NAD+ Precursors (for comparison)

While this article focuses on NAD+ peptide form, common precursors include:

Nicotinamide Riboside (NR): 250-1000 mg daily

Nicotinamide Mononucleotide (NMN): 250-500 mg daily

Nicotinamide: 500-1000 mg daily (flushing side effect)

Note: Direct NAD+ has very poor oral bioavailability (<5%), which is why injection routes are preferred in research.

NAD+ Stacking Research Protocols

Common research combinations:

NAD+ + Resveratrol: Sirtuin activation synergy

NAD+ + CJC-1295 + Ipamorelin: Growth hormone + cellular energy

NAD+ + BPC-157: Tissue repair + energy metabolism

NAD+ + TB-500: Recovery + mitochondrial function

NAD+ + Semaglutide: Metabolic health combination

Reconstitution and Administration

Sanitize vial stopper with alcohol

Add bacteriostatic water or saline:

– 500mg vial + 5mL = 100mg/mL
– 500mg vial + 10mL = 50mg/mL

Swirl gently until fully dissolved

Store in refrigerator at 2-8°C, protected from light

Use within 30 days of reconstitution

For IV: Further dilute in normal saline and administer slowly over 30-60 minutes

NAD+ Side Effects in Research

NAD+ is generally well-tolerated in research settings. Documented side effects include:

Common Side Effects

Flushing and warmth: Transient facial flushing (less than nicotinamide)

Headache: Mild, usually transient

Nausea: At higher doses or rapid infusion

Fatigue: Temporary tiredness after administration

Injection site reactions: Redness, pain, or swelling (SC/IM)

Less Common Side Effects

Dizziness: Particularly with rapid IV infusion

Sweating: Transient perspiration

Insomnia: Some research subjects report difficulty sleeping if dosed late in the day

Muscle cramps: Rare, at very high doses

GI discomfort: Mild digestive upset

Low blood pressure: Transient hypotension with rapid IV

Research Considerations and Cautions

Infusion rate: Slow IV infusion (30-60 min) reduces side effects

Timing: Morning or early afternoon dosing may avoid sleep disruption

Hydration: Adequate water intake supports NAD+ metabolism

Drug interactions: May interact with certain medications (consult research protocols)

Pregnancy/lactation: Not studied, avoid in research

Long-term safety: Data on multi-year use is still limited

Side Effect Management

Reduce dose if side effects occur

Slow IV infusion rate

Administer earlier in the day

Stay well-hydrated

Use antihistamines if flushing is significant

NAD+ vs. NADH: Understanding the Difference

Feature NAD+ (Oxidized) NADH (Reduced) Form Electron acceptor Electron donor Role in metabolism Accepts electrons in catabolism Donates electrons in ETC Cellular ratio Higher in healthy, young cells Accumulates with age/stress Research focus Anti-aging, sirtuin activation Energy production, fatigue Bioavailability Poor oral, good IV Similar Cost Higher Lower Stability More stable Less stable

Key insight: The NAD+/NADH ratio is more important than absolute levels. A high ratio indicates good cellular health and metabolic flexibility.

Purity and Quality Standards

Research-grade NAD+ should meet these criteria:

HPLC purity: ≥98% (target >99%)

Mass spectrometry: Confirms molecular weight of 663.43 g/mol

Endotoxin levels: <0.1 EU/mg for IV research

Appearance: White to off-white lyophilized powder

Solubility: Readily soluble in water and saline

pH: Neutral to slightly acidic in solution

Storage: -20°C for long-term, protected from light and moisture

CoA: Certificate of Analysis should be available

Quality note: NAD+ is sensitive to heat, moisture, and light. Always purchase from suppliers with proper cold-chain storage and third-party testing.

Hanpro Peptides provides third-party tested NAD+ with full CoA documentation, ensuring research-grade quality and consistency.

Where to Buy NAD+ for Research

Hanpro Peptides offers high-purity NAD+:

Purity: >99% HPLC verified

Available sizes: 500mg vials

Format: Lyophilized powder

Worldwide shipping: 7-15 day delivery with tracking

Quality: Third-party tested with CoA available

Storage: Cold-chain shipping available

Support: Research guidance and reconstitution assistance

Purchase NAD+ Online from Hanpro Peptides — trusted by research facilities worldwide.

Related Anti-Aging and Energy Peptides

Explore these complementary research compounds:

MOTS-c — Mitochondrial-derived peptide for metabolism

Epithalon — Telomere and longevity research peptide

FOXO4 — Senolytic peptide research

SS-31 — Mitochondrial protective peptide

CJC-1295 + Ipamorelin — Growth hormone releasing stack

Frequently Asked Questions

What is the difference between NAD+ and NMN/NR?

NAD+ is the active coenzyme itself, while NMN (Nicotinamide Mononucleotide) and NR (Nicotinamide Riboside) are precursors that the body converts into NAD+. Direct NAD+ injection bypasses the conversion steps and provides immediate availability, but has poor oral bioavailability. NMN and NR can be taken orally but require cellular conversion.

How long does NAD+ take to work?

In research settings, immediate effects (increased energy, improved mood) may be noticed within hours of IV administration. More significant effects on biomarkers (sirtuin activity, insulin sensitivity) typically appear after 2-4 weeks of consistent dosing. Anti-aging effects require longer-term studies (3-6 months+).

Can NAD+ reverse aging?

While NAD+ supplementation has shown promising results in reversing certain biomarkers of aging in preclinical research (improved mitochondrial function, DNA repair, insulin sensitivity), it is not a “fountain of youth” and cannot completely reverse the aging process. It is best viewed as a tool to support healthy aging and cellular function.

Is NAD+ safe for long-term use?

NAD+ is generally considered safe in research settings, with most side effects being mild and transient. However, long-term safety data (5+ years) is still limited. Research subjects should be monitored for changes in blood pressure, glucose levels, and liver function. Always follow research protocols and consult with qualified researchers.

What is the best way to administer NAD+?

For research purposes, intravenous (IV) infusion is considered the gold standard due to 100% bioavailability and immediate cellular uptake. Subcutaneous or intramuscular injection offers good bioavailability with more convenient administration. Oral NAD+ has very poor bioavailability (<5%) and is generally not recommended for research requiring reliable dosing.

---

*Disclaimer: This article is for educational and research informational purposes only. NAD+ is a research-use-only compound and is not approved as a drug for human consumption or treatment of any medical condition. All dosage and protocol information is based on preclinical research and does not constitute medical advice.*